The theme of this hybrid meeting is Controversies and uncertainties – Unanswered questions in myeloma. The Michael Morley Lecture – Bispecific Abs and CAR-T: sequencing toxicities and practicalities – will be delivered by Professor Niels van der Donk, Amsterdam University Medical Centre.


Presentations from guest speakers with sessions -

What now for ASCT in myeloma?, Debate: Role of 1st ASCT - do we still need it at all?, Michael Morley Lecture, Debate: Early Treatment vs 'monitoring' in biochemical relapse, Debate: Should we treat high risk smouldering myeloma?


Suitable for Consultants, Trainees, Nurses, Scientists, Pharmacists and anyone working in the field of myeloma.


  • Dr Sally Moore
  • Dr Andrew Charlton
  • Dr Jonathan Sive
  • Dr Rakesh Popat
  • Dr Kirsty Cuthill
  • Dr Ceri Bygrave
  • Professor Guy Pratt
  • Dr Matthew Jenner
  • Prof Niels van der Donk
  • Dr Charlotte Pawlyn
  • Dr Emma Searle
  • Dr Dean Smith
  • Dr Jaimal Kothari

For more information, please contact: [email protected]

  • 09:25 - 20/03/2024 to 16:05 - 20/03/2024
  • Cavendish Conference Centre, 22 Duchess Mews, London, W1G 9DT, United Kingdom